1. Rising Prevalence of Cancer Is One of the Foremost Factors Driving the Histology and Cytology Market
Histology and cytology are among the main tools used in the diagnosis of any cancer. As per the regional analysis, in the United States, according to the National Cancer Institute report of 2018, an estimated 1.73 million new cases of cancer were diagnosed in the United States; nearly 0.61 million people died from the disease. A similar or higher trend is being observed across the developed countries and high emerging markets, such as India and China. The techniques of histology and cytology have been highly useful in the diagnosis of major cancer types, such as breast cancer, lung cancer, sarcoma, and melanoma, among others. The trend toward better sensitivity and specificity, positive and negative predictive values and accuracy makes histological methods more preferred than the cytological methods. However, in certain cancers, such as cervical cancer, the cytological method is more effective. Thus, increasing prevalence is one of the primary factors for the growth of the histology and cytology market.
2. The Cytology Segment is Expected to Lead the Histology and Cytology Market
The cytology segment has a wide range of applications in multiple cancer types. Due to the observations at the cellular levels, the companies primarily prefer cytology-based diagnostic methods. Since in the coming decade, companies are focusing on diagnosis at the molecular level, cytology is expected to play a vital role. The cost of histological tests is higher than cytology studies, mainly due to the multiple phases involved in its preparation, whereas no such stages are classified for cytology slides. Thus, during the forecast period, the demand for cytological methods are expected to grow, with more number of companies exploring the method.
3. Asia-Pacific Expected to Provide Diversified Growth Prospects
The Asia-Pacific region has a huge population density, particularly in the South Asian countries and China, where the people are highly vulnerable to various chronic and life-threatening diseases. A high percentage of the population is diagnosed each year with lung cancer in countries like China, India, Japan, South Korea, and Indonesia. The increasing geriatric population and raising awareness about cancer screening in these countries, along with the expansion of private healthcare companies and hospitals collaborating with multinational players and governments, help propel the histology and cytology market.
4. Leading Companies to Watch for
The report also examines the role of the leading players involved in the market. Some of the key players listed in the study are:
Becton Dickinson and Company
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Access the full report to know more about each Key Players, and their Competition
About Histology and Cytology Market
The Mordor Intelligence report estimates that the histology and cytology market is to register a CAGR of nearly 13.0% over the forecast period of 2018-2023. The rising prevalence of cancers, increasing funding for R&D in early detection and diagnosis of diseases, increasing standardization of pathology laboratories, and technological investment in molecular techniques are some of the primary growth factors for the market.
Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients across the world.